| scholarly article | Q13442814 |
| P50 | author | Ulf H Beier | Q59006483 |
| P2093 | author name string | Wayne W Hancock | |
| Liqing Wang | |||
| Yujie Liu | |||
| Tatiana Akimova | |||
| P2860 | cites work | Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? | Q83125659 |
| Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells | Q83176706 | ||
| Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin | Q84307121 | ||
| FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression | Q24300168 | ||
| Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain | Q24311550 | ||
| Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes | Q24338109 | ||
| The many roles of histone deacetylases in development and physiology: implications for disease and therapy | Q24628821 | ||
| MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components | Q24648543 | ||
| Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation | Q24649964 | ||
| Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues | Q24670176 | ||
| The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses | Q24796904 | ||
| Lysine acetylation targets protein complexes and co-regulates major cellular functions | Q27860589 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function | Q28508365 | ||
| Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells | Q28511811 | ||
| HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage | Q28569045 | ||
| Valproic acid attenuates inflammation in experimental autoimmune neuritis | Q28575981 | ||
| The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men | Q29619117 | ||
| Acetylation and deacetylation of non-histone proteins | Q29619636 | ||
| Epigenetic control of the foxp3 locus in regulatory T cells | Q33273617 | ||
| Specific activity of class II histone deacetylases in human breast cancer cells | Q33606021 | ||
| Class II histone deacetylases: from sequence to function, regulation, and clinical implication | Q33724483 | ||
| Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis | Q33828002 | ||
| Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy | Q33917765 | ||
| Helios expression is a marker of T cell activation and proliferation. | Q34019821 | ||
| Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs | Q34050126 | ||
| Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells | Q34617154 | ||
| Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies | Q34652570 | ||
| Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. | Q34742199 | ||
| Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer | Q35016934 | ||
| HDAC inhibition in lupus models | Q35016981 | ||
| HDAC inhibition and graft versus host disease | Q35016985 | ||
| Phosphoproteomic analysis reveals an intrinsic pathway for the regulation of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes | Q35034012 | ||
| DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination | Q35048728 | ||
| STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction | Q35061825 | ||
| Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells | Q35096555 | ||
| The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2 | Q35160462 | ||
| An epigenetic view of helper T cell differentiation | Q35164202 | ||
| CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game | Q35178495 | ||
| Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. | Q35300659 | ||
| Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity | Q35309505 | ||
| Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells | Q35990736 | ||
| Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. | Q36014379 | ||
| Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases | Q36141408 | ||
| Transcriptional activation of histone genes requires NPAT-dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G1/S phase transition | Q36421122 | ||
| p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells | Q36489810 | ||
| High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner | Q36530189 | ||
| HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen. | Q36534267 | ||
| TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. | Q36893657 | ||
| Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor | Q36963764 | ||
| CD4+ T-regulatory cells: toward therapy for human diseases. | Q37211300 | ||
| HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells. | Q37340316 | ||
| At the crossroads of T helper lineage commitment-Epigenetics points the way. | Q37375215 | ||
| Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance | Q37378417 | ||
| Histone deacetylases: salesmen and customers in the post-translational modification market. | Q37389553 | ||
| Regulatory T cells overturned: the effectors fight back | Q37412624 | ||
| Enhanced antitumor activity induced by adoptive T-cell transfer and adjunctive use of the histone deacetylase inhibitor LAQ824. | Q37426386 | ||
| T-bet dependent removal of Sin3A-histone deacetylase complexes at the Ifng locus drives Th1 differentiation | Q37478410 | ||
| Plasticity of CD4(+) FoxP3(+) T cells | Q37509592 | ||
| Histone deacetylase inhibitors: current status and overview of recent clinical trials | Q37595483 | ||
| Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells | Q37621254 | ||
| Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. | Q37632479 | ||
| Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function | Q37792465 | ||
| Inhibition of histone deacetylases in inflammatory bowel diseases | Q37848684 | ||
| Function of histone deacetylase inhibitors in inflammation. | Q37899219 | ||
| Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression | Q39247455 | ||
| Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs. | Q39502973 | ||
| Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. | Q39765588 | ||
| HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2. | Q39952254 | ||
| Histone deacetylase inhibitors induce antigen specific anergy in lymphocytes: a comparative study | Q40287945 | ||
| Rapid alteration of microRNA levels by histone deacetylase inhibition | Q40322140 | ||
| Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells | Q40439850 | ||
| Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes | Q40687886 | ||
| Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells | Q40835298 | ||
| Acetylation of RNA Processing Proteins and Cell Cycle Proteins in Mitosis | Q42136568 | ||
| The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. | Q42163084 | ||
| Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis | Q42571975 | ||
| CBP/p300 histone acetyl-transferase activity is important for the G1/S transition | Q42801428 | ||
| MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis | Q43069570 | ||
| Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells | Q43296075 | ||
| Histone deacetylase inhibitors: a new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression | Q44189598 | ||
| Discrete roles for histone acetylation in human T helper 1 cell-specific gene expression | Q44997621 | ||
| Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors | Q46055067 | ||
| DNA methylation controls Foxp3 gene expression | Q46391168 | ||
| Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells | Q46490320 | ||
| Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice | Q46808312 | ||
| T cell tolerance induced by histone deacetylase inhibitor is mediated by P21cip1. | Q46910831 | ||
| Deacetylase inhibition promotes the generation and function of regulatory T cells. | Q46961808 | ||
| Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. | Q47765824 | ||
| Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis | Q47927518 | ||
| T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes | Q50111962 | ||
| Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. | Q51045931 | ||
| Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. | Q51765584 | ||
| Expansion of activated human naïve T-cells precedes effector function. | Q52009198 | ||
| Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1. | Q52932701 | ||
| Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. | Q53613759 | ||
| Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment | Q56879954 | ||
| Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells | Q58234949 | ||
| The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease | Q58317005 | ||
| Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients | Q80154346 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 2443-2451 | |
| P577 | publication date | 2012-01-12 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Histone/protein deacetylases and T-cell immune responses | |
| P478 | volume | 119 |
| Q38217594 | Cellular immunotherapy strategies for Ewing sarcoma |
| Q39055861 | Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders |
| Q38924569 | Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy |
| Q41885967 | Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation |
| Q26998898 | Developing Combined HIV Vaccine Strategies for a Functional Cure |
| Q35818676 | Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4+Foxp3+ Regulatory T Cells |
| Q42463384 | Effect of histone deacetylase inhibitor JNJ-26481585 in pain |
| Q54504613 | Effects of histone deacetylase inhibitors on alloresponses. |
| Q38096822 | Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials |
| Q38431356 | Emerging approaches for histone deacetylase inhibitor drug discovery |
| Q39142245 | Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases |
| Q36357400 | Epigenetic drugs: a novel anti-aging strategy? |
| Q38838643 | Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors |
| Q88453278 | Epigenetics of Aberrant Cardiac Wound Healing |
| Q26772330 | Epigenetics of Peripheral B-Cell Differentiation and the Antibody Response |
| Q37082640 | Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism |
| Q37490660 | Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors |
| Q34379613 | HDAC1 controls CD8+ T cell homeostasis and antiviral response |
| Q33566569 | HDAC4 is expressed on multiple T cell lineages but dispensable for their development and function |
| Q57143889 | Histone deacetylase function in CD4 T cells |
| Q35029450 | Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans |
| Q38763747 | Histone deacetylase inhibitors as immunomodulators in cancer therapeutics |
| Q27324527 | Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes |
| Q42815246 | Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model. |
| Q34647217 | Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses |
| Q38240733 | Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders |
| Q64914861 | Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy. |
| Q38866711 | Impact of acetylation on tumor metabolism. |
| Q96155591 | Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction |
| Q64120396 | MEF-2 isoforms' (A-D) roles in development and tumorigenesis |
| Q92071968 | Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function |
| Q97518968 | Metabolic Reprogramming in CD8+ T Cells During Acute Viral Infections |
| Q92173163 | NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes |
| Q38727211 | Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV. |
| Q30579284 | Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators |
| Q40081751 | Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma |
| Q36115749 | SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells |
| Q36525896 | Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1. |
| Q30275552 | Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ. |
| Q39575774 | T cell signaling targets for enhancing regulatory or effector function |
| Q57712790 | Targeting transcription factor lysine acetylation in inflammatory airway diseases |
| Q37034469 | The Effect of Latency Reversal Agents on Primary CD8+ T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication |
| Q47975522 | The Effects of Histone Deacetylase Inhibition on the Levels of Cerebral Cytokines in an Animal Model of Mania Induced by Dextroamphetamine |
| Q28076473 | The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy |
| Q35673349 | The Regulatory T Cell Lineage Factor Foxp3 Regulates Gene Expression through Several Distinct Mechanisms Mostly Independent of Direct DNA Binding |
| Q37144949 | The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function |
| Q36361960 | The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells. |
| Q64099722 | The emerging role of epigenetics in human autoimmune disorders |
| Q24294822 | The functional interactome landscape of the human histone deacetylase family |
| Q37326217 | Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance |
| Q34541123 | Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression |
Search more.